# Eli Lilly and Company (LLY) — Q2-2014 Earnings Results

**Report date:** 2014-07-24 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q2-2014

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Up 0.19%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.68 | N/A | +5.10% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's financial health. They highlighted their commitment to innovation and growth.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They emphasized ongoing efforts to enhance product offerings and market presence.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report shows a positive surprise in EPS, which contributed to a slight increase in the stock price. Investors may view this as a sign of the company's resilience, even without revenue figures. The stock's modest gain reflects a generally favorable reception to the earnings news.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q2-2014_